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. Two experts discuss what this means for understanding the basic cell biology involved and its relevance to treating diabetes.
Kenneth S. Zaret
Pancreatic α-and β-cells are normally very stable: the cells live for a year or more, and when they divide, α-cells make α-cells and β-cells make β-cells. However, various types of damage to the pancreas and other internal organs can cause unexpected changes in cell type. In rats, for example, a toxic diet can cause liver cells to form in the pancreas 2 and intestinal cells to form in the liver 3 . Also, chronic tissue damage such as that caused by stomachacid reflux into the oesophageal epithelium can lead to similar abnormal cell-type changes, as well as cancer 4 . For the most part, these 'transdifferentiation' phenomena have remained at the fringes of cell biology, largely because the events are rare and the initiating cells in which the conversions occur were not identified. Thorel and colleagues' study 1 provides a notable advance because the authors were able to genetically mark and follow the conversion of α-cells to β-like cells under conditions of extreme damage to the pancreatic β-cells (Fig. 1) . Their observations set the stage for dissecting and controlling the cell-conversion process.
Is the generation of β-like cells from α-cells, after extreme β-cell damage, a mechanism of last resort that has evolved for the animal's survival? In times of starvation, animals may eat food far outside their normal diet. Toxic substances that are thereby ingested could acutely damage vital organs, favouring extreme ThE pApER In BRIEF • Thorel et al.
1 (page 1149 of this issue) chemically destroyed more than 99% of β-cells in adult transgenic mice (Fig. 1 ).
• The mice were kept alive with insulin treatment, and β-cell regeneration was studied.
• Replication of the rare surviving β-cells could not account for the regenerated population.
• Instead, the new β-cells arose from direct reprogramming of pancreatic α-cells.
mechanisms of regeneration that might result in cells that are only partially functional. Alternatively, could it be that the emergence of the β-like cells reflects an inherent plasticity of the differentiated state that, although fascinating to biologists, has no true physiological advantage?
In either case, understanding the signals that elicit such regeneration could provide unexpected insight into ways of manipulating cell differentiation for regenerative therapy. Specifically, defining the crucial extracellular components that initiate and maintain α-cell to β-cell conversion, as well as the necessary response pathways within the α-cell, should allow the conversion process to be enhanced by adding appropriate agonists of β-cell fate and antagonists of α-cell fate. (Such informa--tion might be more easily gleaned from in vitro assays of the α-to β-cell conversion.) The relevant signalling pathways would probably include those involved in the initial selection of α-and β-cells from their common pro--genitors during development, and pathways associated with sensing local damage and triggering inflammatory responses in the relevant tissue.
Thorel and colleagues' approach to cell reprogramming differs strikingly from those used previously 5, 6 , which typically involved virus-mediated introduction of regulatory genes to short-circuit a differentiated state and convert cells directly to another fate. The use of viral vectors can lead to unwanted inflammatory effects, which themselves may facilitate cell conversion 7 . It is important, therefore, to understand the signalling milieu in both of these contexts 1, 5, 6 . Such information could help to enhance the generation of β-cells from stem cells, rather than from their sister α-cells. Until there is a cure for type 1 diabetes, we are not in a position to reject any unforeseen means by which β-cells can be regenerated. 
Morris F. White
Pancreatic β-cells secrete insulin, a hormone that is essential for the maintenance of physiological levels of blood glucose. In diabetes, β-cells are destroyed (type 1 diabetes) or their numbers and function are insufficient to compensate for insulin resistance (type 2 diabetes). Both types of diabetes result in abnormally high blood glucose levels and can cause kidney, eye and nerve damage, as well as cardiovascular disease.
Finding ways to restore the pancreatic β-cell population in patients with type 1 diabetes, or replace dysfunctional β-cells in patients with type 2 disease, is a challenging problem of top clinical priority. The transplantation of donor islets of Langerhans might eventually work, but this strategy is impractical in the near future, because high-quality donor islets are in short supply and have a limited useful lifespan after transplantation. So new ways to come up with healthy β-cells and cure diabetes are under investigation in laboratories around the world; these approaches include inducing the generation of β-cells from embryonic stem cells, the replication of existing β-cells and the conversion of other pancreatic cells into functional β-cells 8 .
There has been progress on all fronts, especially in identifying transcriptional programs and signalling cascades that can be exploited to make β-cells from stem cells 9 . But Thorel et al.
1 avoided investigating elaborate cellbased or pathway-based strategies for coaxing stem cells into β-cells. Instead, they carefully manipulated mice to show that mammals facing a fatal shortage of β-cells due to damage to the islets can restore them naturally by converting pre-existing glucagon-producing α-cells into insulin-producing cells -at least when an autoimmune response typical of type 1 diabetes is out of the picture. The pro cess is slow, taking nearly five months before there are sufficient numbers of β-cells to control glucose levels. And no cell division is involved, as all the new β-cells come from pre-existing α-cells.
Previous experiments 10 , in which most of the pancreas was surgically removed to approximate β-cell deficiency, indicated that β-cell regeneration occurs by the replication of But even so, it seems odd that, once new β-cells have been made from the conversion of α-cells, β-cell replication doesn't take over to further expand their repertoire. Eventually, it might also be important to replace the converted/depleted α-cells to maintain a correct glucagon-insulin ratio. Although some of the new cells seem to produce both insulin and glucagon, suggesting that the conversion is difficult to achieve completely (Fig. 1) , Thorel and colleagues' result is truly surprising. It reveals a previously unknown flexibility in the functioning of the pancreas in relation to hormone secretion, with the potential for exploiting it to cure diabetes. Indeed, an ideal solution would be to produce an oral medicine that could orchestrate this process 1 reproducibly and quickly in humans, and drive the total conversion to β-cells to avoid problems created by the co-secretion of insulin and glucagon.
The possibility of pursuing this work 1 as a starting point for research into alternative therapies for diabetes is especially intriguing, because, in patients with diabetes, α-cells are usually healthy and abundant. So the interconversion of α-to β-cells could provide a revolutionary approach to curing diabetes. But we're not there yet, and tough roadblocks lie ahead before such an approach becomes feasible.
As with all strategies, the destruction of new β-cells through autoimmunity in patients with type 1 diabetes will need to be managed. And it remains to be seen whether sufficient β-cells differentiate and survive in patients to cure their diabetes for life. Let us hope that Thorel and colleagues' work sparks other studies to achieve such a cure. Entanglement between particles permits the quantum uncertainty in one variable to be reduced at the cost of increasing that in another.
Condensates are an ideal system in which this technique can be studied.
Entanglement is a feature of quantum mechanics that allows seemingly impossible correlations between nominally independent particles. It has puzzled physicists and philoso phers since it was first proposed, but has been experimentally verified in several systems and is now being developed for applications such as quantum computing, quantum communication and quantum metrology. Actually implementing these applications can be quite challenging, however. In this issue, two groups, Riedel et al. 1 (page 1170) and Gross et al. 2 (page 1165), report the observation of a particularly useful form of entanglement in a Bose-Einstein condensate -a sample of ultracold atoms that are all in the same quantum state. Condensates have become a workhorse for atomic physics experiments because they are relatively convenient to produce and manipulate. These results should therefore make many entanglement applications more feasible.
To understand the results 1,2 , think of the atoms in a condensate as toy spinning tops floating in space (Fig. 1, overleaf) . The spin axes of the atoms all point in the same arbitrary direction. However, the uncertainty principle of quantum mechanics dictates that when the orientation of an atom is measured, a spread of values is obtained in both the vertical and horizontal directions. The spread is represented by the green regions in Figure 1a and b. This orientation uncertainty can be reduced by averaging the measurement over all the atoms, but it can never be eliminated: for a given number of atoms, the uncertainty region has a minimum area determined by the laws of quantum mechanics. It turns out that the axis orientation is the essential variable in many precision atomic measurements, so this quantum limit to accuracy is important.
Entanglement is useful here because it permits the uncertainty in the axis orientation
